Myriad announces $50 million accelerated share repurchase program
Myriad Genetics announced the company has entered into an accelerated share repurchase agreement with Bank of America under which the company will repurchase $50 million of its common stock. Myriad currently has $161 million remaining on its existing share repurchase authorization. November 19, 2018